Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

AstraZeneca reported $9.43B in Gross Profit on Sales for its fiscal quarter ending in September of 2023.

Gross Profit On Sales Change Date
AbbVie USD 7.46B 2.2B Sep/2023
Alcon AG USD 1.29B 75M Sep/2023
Almirall EUR 359.69M 23.71M Jun/2023
Amgen USD 5.1B 119M Sep/2023
Artemis Alpha GBP -16320000 10.05M Jun/2022
AstraZeneca USD 9.43B 15M Sep/2023
Bayer EUR 5.53B 796M Sep/2023
Biogen USD 1.87B 7.4M Sep/2023
Bristol-Myers Squibb USD 8.48B 90M Sep/2023
Galapagos EUR 130.64M 30.51M Sep/2023
Gilead Sciences USD 5.49B 329M Sep/2023
GlaxoSmithKline GBP 5.91B 626M Sep/2023
GRIFOLS EUR 631.83M 13.37M Sep/2023
Haleon 1.72B 3M Sep/2023
Hikma Pharmaceutical USD 733M 91M Jun/2023
Lonza CHF 1.11B 134M Jun/2023
Merck EUR 3.01B 152M Sep/2023
Merck USD 12.28B 1.24B Sep/2023
Orion EUR 171.3M 17.7M Sep/2023
Pfizer USD 3.6B 5.73B Sep/2023
Philips EUR 1.93B 29M Sep/2023
Recordati EUR 333.36M 11.25M Sep/2023
Regeneron Pharmaceuticals USD 2.93B 173.1M Sep/2023
Roche Holding CHF 22.16B 123M Jun/2023
UCB EUR 1.79B 24M Jun/2023